Multicenter Evaluation of Seegene Anyplex TB PCR for the Detection of Mycobacterium tuberculosis in Respiratory Specimens
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Culture is the gold standard for diagnosis of tuberculosis, but it takes 6 to 8 weeks to confirm the result. This issue is complemented by the detection method using polymerase chain reaction, which is now widely used in a routine microbiology laboratory. In this study, we evaluated the performance of the Seegene Anyplex TB PCR to assess its diagnostic sensitivity and specificity, and compared its results with the Roche Cobas TaqMan MTB PCR, one of the most widely used assays in the world. Five university hospitals located in the Chungcheong area in South Korea participated in the study. A total of 1,167 respiratory specimens ordered for acid-fast bacilli staining and culture were collected for four months, analyzed via the Seegene Anyplex TB PCR, and its results were compared with the Roche Cobas TaqMan MTB PCR. For detection of Mycobacterium tuberculosis, the diagnostic sensitivity and specificity of the Anyplex TB PCR were 87.5% and 98.2% respectively, whereas those of the Cobas TaqMan were 92.0% and 98.0% respectively (p value > 0.05). For smear-positive specimens, the sensitivity of the Anyplex TB PCR was 95.2%, which was exactly the same as that of the Cobas TaqMan. For smear-negative specimens, the sensitivity of the Anyplex TB PCR was 69.2%, whereas that of the Cobas TaqMan TB PCR was 84.6%. For detection of MTB, the Seegene Anyplex TB PCR showed excellent diagnostic performance, and high sensitivity and specificity, which were comparable to the Roche Cobas TaqMan MTB PCR. In conclusion, the Anyplex TB PCR can be a useful diagnostic tool for the early detection of tuberculosis in clinical laboratories.
Abstract
Culture is the gold standard for diagnosis of tuberculosis, but it takes 6 to 8 weeks to confirm the result. This issue is complemented by the detection method using polymerase chain reaction, which is now widely used in a routine microbiology laboratory. In this study, we evaluated the performance of the Seegene Anyplex TB PCR to assess its diagnostic sensitivity and specificity, and compared its results with the Roche Cobas TaqMan MTB PCR, one of the most widely used assays in the world. Five university hospitals located in the Chungcheong area in South Korea participated in the study. A total of 1,167 respiratory specimens ordered for acid-fast bacilli staining and culture were collected for four months, analyzed via the Seegene Anyplex TB PCR, and its results were compared with the Roche Cobas TaqMan MTB PCR. For detection of Mycobacterium tuberculosis, the diagnostic sensitivity and specificity of the Anyplex TB PCR were 87.5% and 98.2% respectively, whereas those of the Cobas TaqMan were 92.0% and 98.0% respectively (p value > 0.05). For smear-positive specimens, the sensitivity of the Anyplex TB PCR was 95.2%, which was exactly the same as that of the Cobas TaqMan. For smear-negative specimens, the sensitivity of the Anyplex TB PCR was 69.2%, whereas that of the Cobas TaqMan TB PCR was 84.6%. For detection of MTB, the Seegene Anyplex TB PCR showed excellent diagnostic performance, and high sensitivity and specificity, which were comparable to the Roche Cobas TaqMan MTB PCR. In conclusion, the Anyplex TB PCR can be a useful diagnostic tool for the early detection of tuberculosis in clinical laboratories.
참고문헌 (13)
- Antonenka U, "Comparison of Xpert MTB", RIF with ProbeTec ET DTB and Cobas Taqman MTB for direct detection of tuberculosis complex in respiratory specimens, 2013, pp.13, 280~
- Behr MA, "Transmission of Mycobacterium tuberculosis from patients smear negative for acid-fast bacilli", Lancet, 353, pp.444~449 (1999)
- "Report of an expert consultation on the use of nucleic acid amplification tests for the diagnosis of tuberculosis" (2012)[URL]
- Chang CL, "Survey on changes in mycobacterial testing practices in Korean Laboratories", Korean J. Clin. Microbiol, 4, pp.108~114 (2001)
- Kim JH, "Evaluation of Cobas Taqman MTB PCR for detection of Mycobacterium tuberculosis", J. Clin. Microbiol, 49, pp.173~176 (2011)
- Lawn SD, "Advances in tuberculosis diagnostics:the Xpert MTB", RIF assay and future prospects for a pointof-care test, 2013, pp.13, 349~361
- Sarmiento OL, "Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis", J. Clin. Microbiol, 41, pp.3233~3240 (2003)
- Steingart KR, "Xpert MTB", RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, 2014, pp.21, 1~
- Stewart SM., "The bacteriological diagnosis of tuberculosis meningitis", J. Clin. Pathol, 6, pp.241~242 (1953)
- Tortoli E, "Clinical validation of Xpert MTB", RIF for the diagnosis of extrapulmonary tuberculosis, 2012, pp.40, 442~447
- Tortoli E, "Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples?", J. Clin. Microbiol, 50, pp.2810~2813 (2012)
- Global tuberculosis report 2013, "World Health Organization", ~, pp.Publication No. WHO (2013), HTM[DOI]
- Yang YC, "Evaluation of the Cobas Taqman MTB test for direct detection of Mycobacterium tuberculosis complex in respiratory specimen", J. Clin. Microbiol, 49, pp.797~801 (2011)